Integrative Molecular Scaffold Generation of PI3K/mTOR Inhibitors Using DeepSARM and Ligand-Based Virtual Screening

Kenichiro Shimokawa1, Yumi N Imai1, Yasuyoshi Arikawa1

  • 1Chordia Therapeutics Inc., Fujisawa, Kanagawa, Japan.

Chemmedchem
|July 8, 2026
PubMed